You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

drug-susceptible tuberculosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

Not yet recruiting
  • Tuberculosis
  • Human Immunodeficiency Virus
  • Optimised rifamycin
  • (no location specified)
Oct 8, 2022

HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

Recruiting
  • HIV/AIDS
  • Tuberculosis, Pulmonary
  • Biktarvy®
  • TLD- fixed-drug combination single tablet
  • Durban, KwaZulu-Natal, South Africa
    CAPRISA Springfield Clinical Research Site
Mar 14, 2022

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)

Recruiting
  • Pulmonary Tuberculosis
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Dec 14, 2021

Tuberculosis Trial in Groningen (Amikacin Inhalation Dry Powder, Amikacin Injectable Product)

Recruiting
  • Tuberculosis
  • Amikacin Inhalation Dry Powder
  • Amikacin Injectable Product
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 30, 2021

Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,

Recruiting
  • Pulmonary TB
  • Delamanid + Bedaquiline + OPC-167832 10 mg
  • +3 more
  • Tembisa, Gauteng, South Africa
  • +7 more
Jun 30, 2022

Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)

Not yet recruiting
  • Rifampicin Susceptible Pulmonary Tuberculosis
  • Cape Town, Bellville, South Africa
    TASK Clinical Research Centre
Sep 11, 2023

Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)

Recruiting
  • Tuberculosis, Pulmonary
  • H56:IC31
  • Placebo
  • Bellville, Cape Town, South Africa
  • +5 more
Sep 27, 2021

Tuberculosis, Pulmonary Trial (Cephalexin, Amoxicillin-Clavulanate 500 Mg-125 Mg Oral Tablet, Standard of care treatment of

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Dec 15, 2022

Tuberculosis, Pulmonary Trial in Kaohsiung, Taipei, Taoyuan City (4-month rifapentine-based regimen)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • 4-month rifapentine-based regimen
  • Kaohsiung, Taiwan
  • +3 more
Apr 22, 2021

Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)

Recruiting
  • Tuberculosis, Pulmonary
  • Sanfetrinem Cilexetil
  • +2 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 19, 2022

Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)

Completed
  • Pulmonary Tuberculosis
  • Meropenem 6g IV over 6 hours
  • +9 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 31, 2023

Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) Trial in Cape Town (BVL-GSK098 9mg, Ethionamide 250mg,

Not yet recruiting
  • Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
  • BVL-GSK098 9mg
  • +3 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jul 26, 2022

Tuberculosis Trial in Worldwide (Rifampin)

Not yet recruiting
  • Tuberculosis
  • Groningen, Netherlands
  • +4 more
Feb 22, 2021

Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

Not yet recruiting
  • Drug-resistant Tuberculosis
  • +2 more
  • Targeted next-generation sequencing
  • Cape Town, South Africa
    South African National Health Laboratory Service
Sep 23, 2022

Pulmonary TB Trial in Islamabad (New management mode)

Recruiting
  • Pulmonary TB
  • New management mode
  • Islamabad, Islammabd, Pakistan
  • +1 more
Nov 30, 2020

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    d to Treat Drug Sensitive Tuberculosis in Breastfeeding

    Recruiting
    • Tuberculosis Active
    • +2 more
    • First line tuberculosis treatment
    • Kampala, Uganda
      Infectious Diseases Institute
    Apr 22, 2023

    Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)

    Recruiting
    • Tuberculosis
    • +2 more
    • N acetyl cysteine
    • Bangkok, Thailand
      Faculty of Medicine, Siriraj Hospital
    Feb 12, 2023

    Tuberculosis Trial in H?i Phòng (Community based TB intervention)

    Not yet recruiting
    • Tuberculosis
    • Community based TB intervention
    • Hải Phòng, Vietnam
    • +1 more
    Dec 15, 2022

    Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

    Not yet recruiting
    • Pulmonary Tuberculosis
    • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
    • +3 more
    • (no location specified)
    Jul 25, 2023

    Tuberculosis Trial in Cape Town (Meropenem Injection, Amoxicillin Clavulanate, Pyrazinamide)

    Completed
    • Tuberculosis
    • Meropenem Injection
    • +4 more
    • Cape Town, Western Cape, South Africa
      TASK Clinical Research Centre
    Jan 24, 2022

    Interferon Gamma Injections in Drug-resistant Pulmonary

    Recruiting
    • Pulmonary Tuberculosis
    • Moscow, Russian Federation
      FSBI "NMIC FPI" of the Ministry of Health of Russia
    May 31, 2022